Company

Management Management

  • Management
  • Scientific Advisory Board
Eun Ju Ryu
President /  Eun Ju Ryu

Eun Ju Ryu received her Bachelor’s degree in Pharmacy at Ewha Womans University, Master's in Clinical Pharmacy at Sookmyung Women's University, and MBA degree at New York University in the US. Her 30 years career started as a Regulatory manager, then expanded roles in several companies as a Clinical Trial Management team lead and Marketing team lead. While she was working as a Head of Oncology and Specialty Business Unit at Pfizer Korea, she got promoted as a Japan Asia Regional Commercial lead based in New York headquarter in 2006. Once moved to US, she was leading Global Marketing and Portfolio Maximization and Acquisition in various therapeutic areas including Oncology, Rare Disease, Anti-Infectives, and Neuroscience. She was awarded by the Korean Minister of Health and Welfare for her contribution in US-Korea collaboration, and later received Asian MBA leader’s award as well. Her continuous community service has been recognized by the Bergen County Community leadership award. She also worked as a CEO of Korean Community Center and a Chief Business Development Officer in Diagnostic Company. Eun Ju joins as President of Samyang Biopharm USA in end of Jan. 2022

  • Professor and Chairman, Department of Oncology, Georgetown University Medical Center
  • Director, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center
  • Professor and Leader, Department of Oncology Cancer Immunotherapy Program
  • Professor and Leader, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco
  • AbbVie Foundation Professor, Cancer Immunotherapy, Departments of Pathology, Medicine and the Ben May Department for Cancer Research
  • AbbVie Foundation Professor, University of Chicago
  • Louis M. Weiner
    Louis M. Weiner
  • Lawrence Fong
    Lawrence Fong
  • Professor and Chairman, Department of Oncology, Georgetown University Medical Center
  • Director, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center
  • Professor and Leader, Department of Oncology Cancer Immunotherapy Program
  • Professor and Leader, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco
  • Thomas F. Gajewski
    Thomas F. Gajewski
  • AbbVie Foundation Professor, Cancer Immunotherapy, Departments of Pathology, Medicine and the Ben May Department for Cancer Research
  • AbbVie Foundation Professor, University of Chicago

inquiry